Skip to main content
Top

12-01-2016 | Psoriatic arthritis | Book Chapter | Article

19. Radiographic Assessment of Psoriatic Arthritis (PsA)

Authors: Javier Rosa, MD, Percival D. Sampaio-Barros, MD, PHD, Enrique Roberto Soriano, MD, MSC

Publisher: Springer International Publishing

Abstract

Radiographs are accessible, inexpensive and safe, and therefore remain the generally accepted means for imaging assessment of joint disease in PsA. Radiographs can help in making a diagnosis of PsA, are useful in differentiating PsA from other diseases, and have been used as an outcome measure in the clinical trials and observational studies in PsA. Although there are not specific radiographic features in PsA, there are some typical characteristics that are very useful, and should prompt the physician to think about PsA. These are discussed and described in this chapter, and include: predilection for the distal interphalangeal (DIP) joints of the hands and interphalangeal joint of the great toe, the absence of juxta-articular osteopenia, the presence of large erosions with bony proliferation (pencil-in-cup image), the presence of osteolysis and ankylosis (sometimes in the same hand or finger), periostitis, and the presence of enthesal erosions and calcifications. We also discuss the importance of baseline radiographs in disease prognosis, and the different radiographs scoring methods that have been validated for use in PsA clinical trials and observational studies.
Literature
1.
Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991;30(4):245–50.PubMedCrossRef
2.
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) – an analysis of 220 patients. Q J Med. 1987;62(238):127–41.PubMed
3.
Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis. 2005;64 Suppl 2:ii55–7. doi:10.​1136/​ard.​2004.​033928.PubMedPubMedCentral
4.
Siannis F, Farewell VT, Cook RJ, Schentag CT, Gladman DD. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis. 2006;65(4):478–81. doi:10.​1136/​ard.​2005.​039826.PubMedPubMedCentralCrossRef
5.
Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol. 1995;22(4):675–9.PubMed
6.
Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis. 2003;62(1):68–70.PubMedPubMedCentralCrossRef
7.
Anandarajah A. Imaging in psoriatic arthritis. Clin Rev Allergy Immunol. 2013;44(2):157–65. doi:10.​1007/​s12016-012-8304-4.PubMedCrossRef
8.
Naredo E, Moller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, Mayordomo L, Moragues C, Uson J, de Agustin JJ, Martinez A, Rejon E, Rodriguez A, Dauden E, Ultrasound School of the Spanish Society of R, Spanish ECOAG. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford). 2011;50(10):1838–48. doi:10.​1093/​rheumatology/​ker078.CrossRef
9.
Freeston JE, Coates LC, Nam JL, Moverley AR, Hensor EM, Wakefield RJ, Emery P, Helliwell PS, Conaghan PG. Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound. Arthritis Care Res. 2014;66(3):432–9. doi:10.​1002/​acr.​22158.CrossRef
10.
Ostergaard M, Poggenborg RP. Magnetic resonance imaging in psoriatic arthritis – update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39(2):408–12. doi:10.​3899/​jrheum.​111235.PubMedCrossRef
11.
Coates LC, Hodgson R, Conaghan PG, Freeston JE. MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2012;26(6):805–22. doi:10.​1016/​j.​berh.​2012.​09.​004.PubMedCrossRef
12.
Taylor WJ, Porter GG, Helliwell PS. Operational definitions and observer reliability of the plain radiographic features of psoriatic arthritis. J Rheumatol. 2003;30(12):2645–58.PubMed
13.
Haddad A, Chandran V. Arthritis mutilans. Curr Rheumatol Rep. 2013;15(4):321. doi:10.​1007/​s11926-013-0321-7.PubMedCrossRef
14.
Bruzzese V, Marrese C, Ridola L, Zullo A. Psoriatic arthritis mutilans: case series and literature review. J Rheumatol. 2013;40(7):1233–6. doi:10.​3899/​jrheum.​130093.PubMedCrossRef
15.
Lubrano E, Marchesoni A, Olivieri I, D’Angelo S, Palazzi C, Scarpa R, Ferrara N, Parsons WJ, Brunese L, Helliwell PS, Spadaro A. The radiological assessment of axial involvement in psoriatic arthritis. J Rheumatol Suppl. 2012;89:54–6. doi:10.​3899/​jrheum.​120244.PubMedCrossRef
16.
Day MS, Nam D, Goodman S, Su EP, Figgie M. Psoriatic arthritis. J Am Acad Orthop Surg. 2012;20(1):28–37. doi:10.​5435/​JAAOS-20-01-028.PubMedCrossRef
17.
Gofton JP. Report from the subcommittee on diagnostic criteria for ankylosing spondylitis. In: Population studies of the rheumatic diseases. New York: Excerpta Medica; 1966.
18.
Jenkinson T, Armas J, Evison G, Cohen M, Lovell C, McHugh NJ. The cervical spine in psoriatic arthritis: a clinical and radiological study. Br J Rheumatol. 1994;33(3):255–9.PubMedCrossRef
19.
Jacobson JA, Girish G, Jiang Y, Resnick D. Radiographic evaluation of arthritis: inflammatory conditions. Radiology. 2008;248(2):378–89. doi:10.​1148/​radiol.​2482062110.PubMedCrossRef
20.
Sankowski AJ, Lebkowska UM, Cwikla J, Walecka I, Walecki J. Psoriatic arthritis. Pol J Radiol. 2013;78(1):7–17. doi:10.​12659/​PJR.​883763.PubMedPubMedCentralCrossRef
21.
Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol. 1991;30(5):339–45.PubMedCrossRef
22.
Bennett RM. Psoriatic arthritis. In: Arthritis and allied conditions. 9th ed. Philadelphia: Lea & Febiger; 1979.
23.
McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999;42(6):1080–6. doi:10.​1002/​1529-0131(199906)42:​6<1080:​:​AID-ANR2>3.​0.​CO;2-7.PubMedCrossRef
24.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73. doi:10.​1002/​art.​21972.PubMedCrossRef
25.
Martel W, Stuck KJ, Dworin AM, Hylland RG. Erosive osteoarthritis and psoriatic arthritis: a radiologic comparison in the hand, wrist, and foot. AJR Am J Roentgenol. 1980;134(1):125–35. doi:10.​2214/​ajr.​134.​1.​125.PubMedCrossRef
26.
Punzi L, Frigato M, Frallonardo P, Ramonda R. Inflammatory osteoarthritis of the hand. Best Pract Res Clin Rheumatol. 2010;24(3):301–12. doi:10.​1016/​j.​berh.​2009.​12.​007.PubMedCrossRef
27.
Tillett W, Jadon D, Shaddick G, Robinson G, Sengupta R, Korendowych E, de Vries CS, McHugh NJ. Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis. Arthritis Care Res. 2014;66(2):311–7. doi:10.​1002/​acr.​22104.CrossRef
28.
Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42(12):1460–8. doi:10.​1093/​rheumatology/​keg384.CrossRef
29.
van der Heijde D, Sharp J, Wassenberg S, Gladman DD. Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis. 2005;64 Suppl 2:ii61–4. doi:10.​1136/​ard.​2004.​030809.PubMedPubMedCentral
30.
Mease PJ, Antoni CE. Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis. 2005;64 Suppl 2:ii78–82. doi:10.​1136/​ard.​2004.​034157.PubMedPubMedCentral
31.
Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Dunn M, Tsuji W. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. J Rheumatol. 2006;33(4):712–21.PubMed
32.
Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis Rheum. 2007;56(2):476–88. doi:10.​1002/​art.​22379.PubMedCrossRef
33.
Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman DD. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis. 2009;68(5):702–9. doi:10.​1136/​ard.​2008.​092767.PubMedPubMedCentralCrossRef
34.
van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum. 2007;56(8):2698–707. doi:10.​1002/​art.​22805.PubMedCrossRef
35.
Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, Gomez-Reino J, Papp K, Baratelle A, Xu W, Mudivarthy S, Mack M, Rahman MU, Xu Z, Zrubek J, Beutler A. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum. 2012;64(8):2504–17. doi:10.​1002/​art.​34436.PubMedCrossRef
36.
van der Heijde D, Fleischmann R, Wollenhaupt J, Deodhar A, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, Mease PJ. Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol. Ann Rheum Dis. 2014;73(1):233–7. doi:10.​1136/​annrheumdis-2013-203697.PubMedPubMedCentralCrossRef
37.
Kavanaugh A, Ritchlin C, Rahman P, Puig L, Gottlieb AB, Li S, Wang Y, Noonan L, Brodmerkel C, Song M, Mendelsohn AM, McInnes IB, Psummit, Study G. Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. Ann Rheum Dis. 2014;73(6):1000–6. doi:10.​1136/​annrheumdis-2013-204741.PubMedPubMedCentralCrossRef
38.
Proceedings of the annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), June 26–27, 2012, Stockholm, Sweden. J Rheumatol. 2013;40(8):1407–58.